Recherche
-
A novel tool to assess the quality of RWE to guide the management of retinal disease
(Acta Ophtalmologica, 2020-12-28)Article de revueLibre accès -
Risk of inflammation, retinal vasculitis and retinal occlusion-related events with brolucizumab: post-hoc review of HAWK and HARRIER
(Ophthalmology: Journal of The American Academy of Ophthalmology, 2020-11-15)Article de revueLibre accès -
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure
(Graefe's Archive for Clinical and Experimental Ophthalmology. vol. 259, pp. 567–574, 2021-02-02)Article de revueLibre accès -
Efficacy and Treatment Burden of Intravitreal Aflibercept Versus Intravitreal Ranibizumab Treat-and-Extend Regimens at 2 Years: Network Meta-Analysis Incorporating Individual Patient Data Meta-Regression and Matching-Adjusted Indirect Comparison
(Advances in Therapy, 2020)Article de revueLibre accès -
Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
(The British Journal of Ophthalmology. vol. 105, n° 11, 2021-10-21)Article de revueLibre accès -
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: The CENTERA Study
(American Journal of Ophthalmology, 2021-02-06)Article de revueLibre accès -
Real-world outcomes following 12 months of intravitreal aflibercept monotherapy in patients with diabetic macular edema in France: results from the APOLLON study
(Graefe's Archive for Clinical and Experimental Ophthalmology. vol. 258, n° 3, pp. 521-528, 2020)Article de revueLibre accès -
Visual Acuity Gain Profiles and Anatomical Prognosis Factors in Patients with Drug-Naive Diabetic Macular Edema Treated with Dexamethasone Implant: The NAVEDEX Study
(Pharmaceutics. vol. 13, n° 2, 2021-02-01)Article de revueLibre accès